Nanotechnology in Cancer Diagnosis and Treatment

Abstract

Traditional cancer diagnosis has been aided by the application of nanoparticles (NPs), which have made the process easier and faster. NPs possess exceptional properties such as a larger surface area, higher volume proportion, and better targeting capabilities. Additionally, their low toxic effect on healthy cells enhances their bioavailability and t-half by allowing them to functionally penetrate the fenestration of epithelium and tissues. These particles have attracted attention in multidisciplinary areas, making them the most promising materials in many biomedical applications, especially in the treatment and diagnosis of various diseases. Today, many drugs are presented or coated with nanoparticles for the direct targeting of tumors or diseased organs without harming normal tissues/cells. Many types of nanoparticles, such as metallic, magnetic, polymeric, metal oxide, quantum dots, graphene, fullerene, liposomes, carbon nanotubes, and dendrimers, have potential applications in cancer treatment and diagnosis. In many studies, nanoparticles have been reported to show intrinsic anticancer activity due to their antioxidant action and cause an inhibitory effect on the growth of tumors. Moreover, nanoparticles can facilitate the controlled release of drugs and increase drug release efficiency with fewer side effects. Nanomaterials such as microbubbles are used as molecular imaging agents for ultrasound imaging. This review discusses the various types of nanoparticles that are commonly used in cancer diagnosis and treatment.

Advanced strategies for CRISPR/Cas9 delivery and applications in gene editing, therapy, and cancer detection using nanoparticles and nanocarriers

“…PNPs outperform other materials in terms of mechanical strength, electrical conductivity, and optical and thermal properties. 53 To effectively compress negatively charged nucleic acids through electrostatic interactions and produce PNPs, cationic polymers are used. These PNPs significantly reduce the risk of sgRNA, and Cas proteins degrading during delivery, improve targeting, and enable regulated drug release rates in vivo .…”

“…Poly-lactic- co -glycolic acid (PLGA), one of the biodegradable polymers, has grown significantly in popularity as a preferred option for drug delivery, particularly in transdermal applications. 53 The ability of the polymer–lipid hybrid nanoparticle (PLN) system to improve the cellular accumulation and retention of doxorubicin in cancer cell lines that overexpress Pgp was conducted by Wong et al in a study. To do this, they complexed doxorubicin with a novel anionic polymer to produce doxorubicin-loaded PLNs (Dox-PLNs).…”

Circumventing challenges in mitochondrial targeting for cancer treatment: leveraging nanoplatforms for effective solutions

“…Their diverse applications have the potential to revolutionize cancer therapy, elevating precision and effectiveness. 30…”

Inorganic nanoparticle-cored dendrimers for biomedical applications: A review

“…Recently, there has been a dramatic increase in the conception and utilization of nanotechnology within these domains, indicating a significant leap forward in the application of nanotechnology [ [4] , [5] , [6] ]. The nanotechnology industry has emerged as a formidable ally in the healthcare industry, with its applications in biomedicine expanding to encompass early disease detection and sophisticated imaging methodologies, especially in the context of cancers such as breast, lung, colon, prostate, ovarian, and cervix [ [7] , [8] , [9] , [10] , [11] , [12] ]. It is often the case that individuals who are suffering from these conditions are confronted by the difficult challenge of hidden or visible secondary colonies.…”